These compounds may interact with:
Orexin receptor type 1
Potentially involved in: narcolepsy; seasonal affective disorder; pain agnosia; cannabis dependence; mental depression; depressive disorder; schizophrenia; substance withdrawal syndrome; cocaine-related disorders; mood disorders; insomnia
Disease data sourced from Pharos.